How should I manage a new scaling erythematous plaque rash involving the ankles, buttocks, and arms in a 63-year-old woman?

Management of New Scaling Erythematous Plaques in a 63-Year-Old Woman

Based on the clinical presentation of scaling erythematous plaques on the ankles, buttocks, and arms, the most likely diagnosis is psoriasis vulgaris, and you should initiate topical corticosteroid therapy as first-line treatment.

Diagnostic Approach

The distribution pattern strongly suggests psoriasis vulgaris, which classically presents as well-demarcated, red plaques with silvery scale commonly involving the elbows, knees, and presacral region, though any area of skin may be involved 1. The buttocks (presacral region), ankles, and arms are typical locations for psoriatic plaques 1.

Key Differential Diagnoses to Consider:

• Psoriasis vulgaris - Most likely given the distribution (buttocks/presacral area, extremities) and morphology (scaling erythematous plaques) 1

• Erythema annulare centrifugum (EAC) - Consider if lesions show annular or polycyclic configuration with "trailing edge" scale, though this typically presents with arcuate plaques rather than fixed plaques 2, 3

• Tinea corporis - Rule out with potassium hydroxide (KOH) examination of scale scrapings, especially if lesions are pruritic and annular 3

• Nummular eczema - Presents as coin-shaped papulovesicular erythematous lesions, typically more vesicular than psoriatic plaques 3

Severity Assessment

Assess the body surface area (BSA) involved to determine disease severity 1:

• <3% BSA = mild disease
• 3-10% BSA = moderate disease
• ≥10% BSA = severe disease

Important caveat: Psoriasis can be severe irrespective of BSA when it has serious emotional consequences, occurs in high-impact locations (hands, feet, scalp, face, genital area), or causes intractable pruritus 1.

Initial Management Strategy

For Mild to Moderate Disease (Most Likely Scenario):

Initiate topical corticosteroid therapy as the first-line treatment for psoriasis vulgaris 1. The specific potency should be selected based on:

• Body location (mid-potency for trunk/extremities, low-potency for intertriginous areas like buttocks folds)
• Plaque thickness
• Patient tolerance

Diagnostic Confirmation Steps:

1. Perform KOH examination of scale scrapings to exclude tinea corporis before initiating corticosteroid therapy, as steroids can worsen fungal infections 3

2. Consider skin biopsy if the diagnosis remains uncertain after initial evaluation, particularly if the presentation is atypical or treatment-resistant 4, 2

3. Screen for psoriatic arthritis by asking about joint pain, stiffness, or swelling, as psoriasis has systemic inflammatory associations 1

4. Assess for metabolic comorbidities including cardiovascular disease risk factors, as psoriasis is associated with metabolic syndrome, cardiovascular disease, and other systemic conditions 1

Common Pitfalls to Avoid

• Do not assume fungal infection without KOH confirmation - The scaling nature may prompt empiric antifungal treatment, but repeated antifungal therapy without improvement should raise suspicion for alternative diagnoses like psoriasis or neutrophilic figurate erythema 4

• Do not overlook rare mimics - If the rash is treatment-resistant to standard therapies, consider rare entities such as neutrophilic figurate erythema (which requires anti-neutrophil therapy) or chronic recurrent annular neutrophilic dermatosis 4, 5

• Do not miss systemic associations - In a 63-year-old woman with new-onset psoriasis, screen for triggers including medications, infections, and stress, and evaluate for associated comorbidities 1

When to Escalate Care

Refer to dermatology if:

• Diagnosis remains uncertain after initial evaluation
• Disease involves >3-10% BSA requiring systemic therapy consideration
• High-impact areas are involved (face, genitals, hands, feet)
• Significant emotional impact or intractable pruritus is present
• Treatment resistance to appropriate topical therapy after 4-8 weeks 1